Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,934
Total Claims
$587K
Drug Cost
687
Beneficiaries
$854
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-27%
Opioid rate vs peers
2.8% vs 3.8% avg
-27%
Cost per patient vs peers
$854 vs $1,174 avg
+49%
Brand preference vs peers
13.2% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
247
Opioid Claims
$7,872
Opioid Cost
16.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,172 claims · $422K
Generic: 7,715 claims · $162K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 209 | $83K |
| Semaglutide | 45 | $45K |
| Linaclotide | 42 | $22K |
| Rivaroxaban | 53 | $21K |
| Vibegron | 64 | $16K |
| Dulaglutide | 18 | $14K |
| Lipase/Protease/Amylase | 18 | $14K |
| Linagliptin | 53 | $13K |
| Empagliflozin | 30 | $13K |
| Sitagliptin Phosphate | 34 | $13K |
| Dextromethorphan Hbr/Quinidine | 16 | $12K |
| Semaglutide | 14 | $9,609 |
| Opicapone | 32 | $7,496 |
| Atorvastatin Calcium | 519 | $7,398 |
| Finerenone | 26 | $6,812 |
Prescribing Profile
Patient Profile
80
Avg Age
63%
Female
2.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About